Wealth Enhancement Advisory Services, LLC Adaptimmune Therapeutics PLC Transaction History
Wealth Enhancement Advisory Services, LLC
- $44.5 Billion
- Q3 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 10,816 shares of ADAP stock, worth $8,003. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,816
Previous 35,102
69.19%
Holding current value
$8,003
Previous $34,000
70.59%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ADAP
# of Institutions
81Shares Held
152MCall Options Held
78.5KPut Options Held
36.5K-
Matrix Capital Management Company, LP Waltham, MA39MShares$28.8 Million0.29% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA27.4MShares$20.3 Million0.95% of portfolio
-
Nea Management Company, LLC Timonium, MD17.1MShares$12.6 Million1.58% of portfolio
-
Baillie Gifford & CO15.1MShares$11.2 Million0.01% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR12.3MShares$9.14 Million0.49% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $121M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...